Showing results (811-820 of 15,744) with videos related to

Sort By:
Pageof 1,575
The Journal of Antimicrobial Chemotherapy|October 23, 2010
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in FranceDiane Descamps, Marie-Laure Chaix, Brigitte Montes, et al.
The Journal of Antimicrobial Chemotherapy|October 16, 2010
Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosisJurriaan E M de Steenwinkel, Gerjo J de Knegt, Marian T ten Kate, et al.
The Journal of Antimicrobial Chemotherapy|November 20, 2010
Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central ItalySilvia D'Arezzo, Luigi Principe, Alessandro Capone, et al.
The Journal of Antimicrobial Chemotherapy|November 20, 2010
Effect of overexpression of small non-coding DsrA RNA on multidrug efflux in Escherichia coliKunihiko Nishino, Seiji Yamasaki, Mitsuko Hayashi-Nishino, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2010
OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro?Filipa Grosso, Karyne Rangel Carvalho, Sandra Quinteira, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2010
Is non-prescription oseltamivir availability under strict criteria workable? A qualitative study in New ZealandNatalie Gauld, Fiona Kelly, John Shaw
The Journal of Antimicrobial Chemotherapy|November 6, 2010
Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB geneYangsoon Lee, Jinhwa Lee, Seok Hoon Jeong, et al.
The Journal of Antimicrobial Chemotherapy|November 25, 2010
Efavirenz concentrations in CSF exceed IC50 for wild-type HIVBrookie M Best, Peter P Koopmans, Scott L Letendre, et al.
The Journal of Antimicrobial Chemotherapy|October 14, 2010
Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patientsEduardo Seclén, María del Mar González, Mariana Lapaz, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2010
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infectionPeter L Anderson, Jennifer J Kiser, Edward M Gardner, et al.
Pageof 1,575